Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma

Introduction: Lymphoma is a common hematopoietic cancer. Immunosuppression is one of the main risk factors for the development of lymphoma. The interleukin (IL)-1 receptor antagonist IL1RN, which binds to the IL-1 receptor, moderates a variety of immune responses related to IL-1. We aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarani, Hosna, Molashahi, Behrouz, Taheri, Mohsen, Bahari, Gholamreza, Hashemi, Seyed Mahdi, Hashemi, Mohammad, Ghavami, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381109/
https://www.ncbi.nlm.nih.gov/pubmed/34466207
http://dx.doi.org/10.18502/ijhoscr.v15i2.6039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381109/
https://www.ncbi.nlm.nih.gov/pubmed/34466207
http://dx.doi.org/10.18502/ijhoscr.v15i2.6039

Ejemplares similares